Latest Press Releases
View all
TimeHeadline
2h agoThe Results of Phase III OptiTROP-Lung05 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ASCO Oral Presentation and Simultaneously Published in The Lancet
Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H
2h agoKelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCO
Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H
2h agoMax Power Mining Closes $25 Million Strategic Investment From Eric Sprott To Accelerate Commercial Evaluation at Lawson
Max Power Mining Corp
3h agoMach Travel Solutions Delivers Sustained FY26 Performance Despite Challenging Macro- Economic Environment; While Accelerating Transformation into an Integrated Travel Solutions Platform
Mach Conferences And Events Ltd.
4h agoVanta Announces Strategic Private Placement Financing to Advance U.S. Peptide Market Entry and Integrated Longevity and Consumer Health Sciences Platform
Vanta Holdings Inc.
Ggtoor Inc. logo

Ggtoor Inc.

About

0.00USD+0.00 +0.00%
Closed • Updated at 06:33 GMT+00:00
Market Cap$24.1K
Volume435
Beta-202.86
RSI51.00
Consumer Non-DurablesFood: Specialty/Candy

Ggtoor Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Nov 16 2022
GGTOOR, Inc., (OTCMKTS:GTOR) Announces Buyer for Last Reg A Sale for 2,272,727 Defaulted, Shares Remain in Treasury
Nov 8 2022
GGTOOR, Inc. (OTCMKTS:GTOR) Announces it Will Launch GGToor Media Network, a 24-Hour Gaming, Web3, Technology and AI News and Information Network
Nov 2 2022
GGTOOR, Inc. (OTCMKTS: GTOR) Announces Update on Nerdland Purchase and Tournament Results for the Week Ended October 29, 2022
Oct 25 2022
GGTOOR, Inc. (OTCMKTS:GTOR) Announces Its Regulation A Registration Has Been Voluntarily Terminated -- Dilution From Sales of Stock Screeches to a Halt
Oct 19 2022
GGTOOR, Inc., (OTCMKTS:GTOR) Announces Revised Nerdland Commitment to Purchase Agreement has Been Executed

Community Chat

Ask AI

Try asking